9th Circ. Ruling May Help Pharma Cos. Avert Investor Claims
On Aug. 20, the U.S. Court of Appeals for the Ninth Circuit affirmed the dismissal of Sneed v. Talphera Inc., a securities fraud class action. The plaintiffs alleged that a pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article